Evidence map›Paper›PMID 39962381›Full record

ArticleBMC bioinformatics2025

A novel weighted pseudo-labeling framework based on matrix factorization for adverse drug reaction prediction.

Junheng Chen, Fangfang Han, Mingxiu He, Yiyang Shi, Yongming Cai

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Junheng ChenSchool of Medical Information and Engineering, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Fangfang HanSchool of Medical Information and Engineering, Guangdong Pharmaceutical University, Guangzhou, 510006, China. hanff@gdpu.edu.cn.
Mingxiu HeSchool of Medical Information and Engineering, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Yiyang ShiSchool of Medical Information and Engineering, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Yongming CaiSchool of Medical Information and Engineering, Guangdong Pharmaceutical University, Guangzhou, 510006, China. cym@gdpu.edu.cn.

Funding

Research and application of key technology and evaluation system of pharmacovigilance No. 2022ZDZ06
6 · The paper itself

Abstract

Adverse drug reactions (ADRs) are among the global public health events that seriously endanger human life and cause high economic burdens. Therefore, predicting the possibility of their occurrence and taking early and effective response measures is of great significance. Constructing a correlation matrix between drugs and their adverse reactions, followed by effective correlation data mining, is one of the current strategies to predict ADRs using accessible public data. Since the number of known ADRs in real-world data is far less than the number of their unknown counterparts, the drug-ADR association matrix is very sparse, which greatly affects the classification performance of machine learning methods. To effectively address the problem of sparsity, we proposed a novel weighted pseudo-labeling framework that mines potential unknown drug-ADR pairs by integrating multiple weighted matrix factorization (MF) models and treating them as pseudo-labeled drug-ADR pairs. Pseudo-labeled data is added to the training set, and the MF model is fine-tuned to improve the classification performance. To prevent overfitting to easily found pseudo-labels and improve the quality of pseudo-labels, a novel weighting approach for pseudo-labels was adopted. This paper reproduces the baselines under the same experimental conditions to evaluate the performance of the proposed method on sparse data from the Side Effect Resource (SIDER) database. Experimental results showed that our method outperformed other baselines in the Area Under Precision-Recall and F1-scores and still maintained the best performance in sparser scenarios. Furthermore, we conducted a case study, and the results showed that our proposed framework efficiently predicted ADRs in the real world.

Indexed as

Data MiningDrug-Related Side Effects and Adverse ReactionsAlgorithmsHumansMachine LearningAdverse drug reaction predictionMatrix factorizationSemi-supervised learningWeighted pseudo-labeling

Identifiers

PMID39962381
PMCPMC11831795

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.